SQZ Biotech to Participate in June Investor Conferences

On May 26, 2020 SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, reported that Armon Sharei, PhD, chief executive officer, will be presenting at the following upcoming virtual investor conferences (Press release, SQZ Biotech, MAY 26, 2020, View Source [SID1234558485]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies Virtual Healthcare Conference
Tuesday, June 2, 2020
Presentation Time: 3:30pm-3:55pm ET

Raymond James Human Health Innovations Conference
Wednesday, June 17, 2020
Cell Therapy Panel Time: 12:00pm ET

Dr. Sharei and Teri Loxam, chief financial officer will also be holding one on one meetings during the conferences.